Kojima Taiki, Nakahari Hirofumi, Ikeda Makoto, Kurimoto Michihiro
Department of Anesthesiology, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi, 474-8710, Japan.
Division of Comprehensive Pediatric Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
J Anesth. 2025 Feb;39(1):93-100. doi: 10.1007/s00540-024-03436-z. Epub 2024 Dec 1.
The influence of anesthetic interactions on motor-evoked potentials in infants has rarely been reported. In infants, adding a small dose of sevoflurane to propofol-based total intravenous anesthesia is reasonable for reducing propofol administration. We collected preliminary data regarding the effect of low-dose sevoflurane in propofol-based total intravenous anesthesia on motor-evoked potentials in infants.
This pilot interventional study included 10 consecutive infants requiring motor-evoked potentials between January 2023 and March 2024. The motor-evoked potential amplitudes in the upper and lower extremities were recorded twice when general anesthesia was maintained using (1) propofol-based total intravenous anesthesia and (2) 0.1-0.15 age-adjusted minimum alveolar concentration sevoflurane + propofol-based total intravenous anesthesia.
The motor-evoked potential amplitude in the right upper extremity was not significantly different after the addition of a small dose of sevoflurane [192 (75.3-398) μV, 121 (57.7-304) μV, P = 0.19]. All the motor-evoked potential amplitudes in the right lower extremity (quadriceps femoris, anterior tibialis, and gastrocnemius muscles) were significantly attenuated by adding a small dose of sevoflurane (median [interquartile range]: 47.9 [35.4-200] μV, 25.2 [12.4-55.3] μV, P = 0.014; 74.2 [51.9-232] μV, 31.2 [2.7-64] μV, P = 0.0039; 29.8 [20-194] μV, 9.9 [3.8-92.4] μV, P = 0.0039, respectively). Similar results were observed in the left lower extremities.
Adding even 0.1-0.15 age-adjusted minimum alveolar concentration sevoflurane to propofol-based total intravenous anesthesia attenuated the motor-evoked potential amplitudes in the lower extremities. A further prospective interventional study with an appropriate sample size is required to investigate the study hypothesis.
麻醉相互作用对婴儿运动诱发电位的影响鲜有报道。在婴儿中,在丙泊酚全静脉麻醉基础上加用小剂量七氟醚以减少丙泊酚用量是合理的。我们收集了关于低剂量七氟醚在丙泊酚全静脉麻醉中对婴儿运动诱发电位影响的初步数据。
这项前瞻性干预研究纳入了2023年1月至2024年3月期间连续10例需要进行运动诱发电位监测的婴儿。在全身麻醉维持过程中,当使用(1)丙泊酚全静脉麻醉和(2)0.1 - 0.15年龄校正最低肺泡浓度的七氟醚 + 丙泊酚全静脉麻醉时,记录上肢和下肢的运动诱发电位幅度两次。
加用小剂量七氟醚后,右上肢运动诱发电位幅度无显著差异[192(75.3 - 398)μV,121(57.7 - 304)μV,P = 0.19]。加用小剂量七氟醚后,右下肢(股四头肌、胫前肌和腓肠肌)所有运动诱发电位幅度均显著降低(中位数[四分位间距]:47.9 [35.4 - 200] μV,25.2 [12.4 - 55.3] μV,P = 0.014;74.2 [51.9 - 232] μV,31.2 [2.7 - 64] μV,P = 0.0039;29.8 [20 - 194] μV,9.9 [3.8 - 92.4] μV,P = 0.0039)。左下肢也观察到类似结果。
在丙泊酚全静脉麻醉基础上加用即使0.1 - 0.15年龄校正最低肺泡浓度的七氟醚也会降低下肢运动诱发电位幅度。需要进一步进行具有适当样本量的前瞻性干预研究以验证本研究假设。